The Pharma Letter provides subscribers with daily, up-to-date news, business intelligence, comment and analysis for the Pharmaceuticals, Biotechnology and Generics sectors of the overall health care industry, backed by a team of respected writers with many years of experience in the field.
Amgen to acquire US/German biotech firm
27 January 2012
Adding to the strong start this year for M&A activity in the Pharma/Biotech sector, USA-based
Latest Pharma Letter Articles
Celgene to buy Avila; posts strong 4th-qtr results
27 January 2012
USA-based Celgene (Nasdaq: CELG) yesterday revealed that it has entered into a definitive
Bristol-Myers fourth quarter below analysts estimates
27 January 2012
US drug major Bristol-Myers Squibb (NYSE: BMY) posted fourth quarter 2011 net sales of $5.5
Prosensa raises 23 million euros
26 January 2012
Prosensa, the Dutch biopharmaceutical company focusing on RNA-modulating therapeutics for rare
Overview of biologic regulations in India
26 January 2012
Currently, all biologics in India, including innovative and copy biologics are approved as
Department of Justice seeks permanent injunction against Ranbaxy
27 January 2012
The US Department of Justice, on behalf of the Food and Drug Administration, has filed a consent
Kenya court set to deliver ruling on anti-counterfeit law
27 January 2012
After almost three years of waiting since three petitioners living with HIV filed a constitutional
News From the Web
OctoPlus publishes Prospectus for listing of shares issued on 31 October 2011
27 January 2012 | Reuters
Merck predicts huge sales losses upon the expiry of protection for its ...
27 January 2012 | PR Web (press release)
Pharmaceutical giant recalls painkiller, Excedrin in SA
27 January 2012 | Sowetan
Celator® Pharmaceuticals Receives EMA Orphan Drug Status for CPX-351 in Acute ...
27 January 2012 | EON: Enhanced Online News (press release)
FIA to check if Punjab govt followed rules
27 January 2012 | The Nation, Pakistan
Teva Pharmaceutical Industries Ltd (TEVA) Given "Neutral" Rating by Goldman ...
27 January 2012 | LocalizedUSA
Momenta Plunges As Lovenox Fight Tilts Toward Watson
26 January 2012 | Investor's Business Daily
Sandoz launches (Pr)Sandoz* Losartan and Sandoz Losartan HCT
26 January 2012 | DigitalJournal.com (press release)
Bio-security, an emerging challenge
26 January 2012 | Hindu Business Line
Stellar Pharmaceuticals Receives 2nd Uracyst(R) Patent in United States of America
26 January 2012 | MarketWatch (press release)
Auxilium Pharmaceuticals, Inc. Announces First Patients Dosed in XIAFLEX ...
26 January 2012 | MarketWatch (press release)
